UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 23, 2025
Accession Number:
0001493152-25-014228
Submission Type:
POS AM
CIK:
0001815974
Company Name:
Anebulo Pharmaceuticals, Inc.
File Number:
333-268113